Russell CD - Search Results

1

Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Saleh MN, Liu T, Allen LF, Russell CD, Orr RA, Colcher D, Schlom J, et al. Meredith RF, et al. Among authors: russell cd. J Nucl Med. 1992 Jan;33(1):23-9. J Nucl Med. 1992. PMID: 1730991 Free article. Clinical Trial.

2

Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody.

Meredith RF, LoBuglio AF, Plott WE, Orr RA, Brezovich IA, Russell CD, Harvey EB, Yester MV, Wagner AJ, Spencer SA, et al. Meredith RF, et al. Among authors: russell cd. J Nucl Med. 1991 Jun;32(6):1162-8. J Nucl Med. 1991. PMID: 2045929 Free article.

3

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.

Meredith RF, Bueschen AJ, Khazaeli MB, Plott WE, Grizzle WE, Wheeler RH, Schlom J, Russell CD, Liu T, LoBuglio AF. Meredith RF, et al. Among authors: russell cd. J Nucl Med. 1994 Jun;35(6):1017-22. J Nucl Med. 1994. PMID: 8195861 Free article. Clinical Trial.

4

Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.

Meredith RF, Khazaeli MB, Grizzle WE, Orr RA, Plott G, Urist MM, Liu T, Russell CD, Wheeler RH, Schlom J, et al. Meredith RF, et al. Among authors: russell cd. Hum Antibodies Hybridomas. 1993 Oct;4(4):190-7. Hum Antibodies Hybridomas. 1993. PMID: 8257773

5

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.

Meredith RF, Partridge EE, Alvarez RD, Khazaeli MB, Plott G, Russell CD, Wheeler RH, Liu T, Grizzle WE, Schlom J, LoBuglio AF. Meredith RF, et al. Among authors: russell cd. J Nucl Med. 1996 Sep;37(9):1491-6. J Nucl Med. 1996. PMID: 8790200 Free article. Clinical Trial.

6

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.

Alvarez RD, Partridge EE, Khazaeli MB, Plott G, Austin M, Kilgore L, Russell CD, Liu T, Grizzle WE, Schlom J, LoBuglio AF, Meredith RF. Alvarez RD, et al. Among authors: russell cd. Gynecol Oncol. 1997 Apr;65(1):94-101. doi: 10.1006/gyno.1996.4577. Gynecol Oncol. 1997. PMID: 9103398 Clinical Trial.

7

Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Grizzle WE, Liu T, Schlom J, Russell CD, Wheeler RH, LoBuglio AF. Meredith RF, et al. Among authors: russell cd. Clin Cancer Res. 1996 Nov;2(11):1811-8. Clin Cancer Res. 1996. PMID: 9816134 Clinical Trial.

8

Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.

Meredith RF, Khazaeli MB, Macey DJ, Grizzle WE, Mayo M, Schlom J, Russell CD, LoBuglio AF. Meredith RF, et al. Among authors: russell cd. Clin Cancer Res. 1999 Oct;5(10 Suppl):3254s-3258s. Clin Cancer Res. 1999. PMID: 10541372 Clinical Trial.

9

Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma.

Saleh MN, Miller DM, Peterson L, Russell CD, Unger MW, Urist MM, Wheeler RH, LoBuglio AF. Saleh MN, et al. Among authors: russell cd. J Clin Oncol. 1988 Jun;6(6):1059-65. doi: 10.1200/JCO.1988.6.6.1059. J Clin Oncol. 1988. PMID: 3373261

10

Optimum sample times for single-injection, multisample renal clearance methods.

Russell CD. Russell CD. J Nucl Med. 1993 Oct;34(10):1761-5. J Nucl Med. 1993. PMID: 8410295 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters